Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma: A Single-Center Real Life Experience

被引：0
|
作者：
Canto, Chiara [1 ]
Ranucci, Elena [1 ]
Pulini, Stefano [1 ]
Santoleri, Fiorenzo [2 ]
Morelli, Anna Maria [1 ]
Fioritoni, Francesca [1 ]
Falorio, Simona [1 ]
Torti, Lorenza [1 ]
Spadano, Antonio [1 ]
D'Aloisio, Marianna [1 ]
Di Ianni, Mauro [1 ]
Santarone, Stella [1 ]
Di Bartolomeo, Paolo [1 ]
机构：
[1] Santo Spirito Civ Hosp, Dept Hematol Transfus Med & Biotechnol, Pescara, Italy
[2] Santo Spirito Civ Hosp, Hosp Pharm, Pescara, Italy
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-112595
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5653
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Pomalidomide, Cyclophosphamide and Dexamethasone for Relapsed/Refractory Multiple Myeloma: A Retrospective Single Center Experience
    Garderet, Laurent
    Polge, Emmanuelle
    Gueye, Mor Seny
    Kellil, Chaima
    Ova, Jeanny Guelongo Okouango
    Beohou, Eric
    Labopin, Myriam
    Mohty, Mohamad
    [J]. BLOOD, 2015, 126 (23)
  • [2] Pomalidomide, cyclophosphamide, and dexamethasone for relapsed/refractory multiple myeloma patients in a real-life setting: a single-center retrospective study
    Trudel, Sabrina
    Tessoulin, Benoit
    Jullien, Maxime
    Blin, Nicolas
    Gastinne, Thomas
    Mahe, Beatrice
    Dubruille, Viviane
    Bonnet, Antoine
    Lok, Anne
    Chevallier, Patrice
    Peterlin, Pierre
    Garnier, Alice
    Guillaume, Thierry
    Le Bourgeois, Amandine
    Le Gouill, Steven
    Moreau, Philippe
    Touzeau, Cyrille
    [J]. ANNALS OF HEMATOLOGY, 2019, 98 (06) : 1441 - 1447
  • [3] Pomalidomide, cyclophosphamide, and dexamethasone for relapsed/refractory multiple myeloma patients in a real-life setting: a single-center retrospective study
    Sabrina Trudel
    Benoît Tessoulin
    Maxime Jullien
    Nicolas Blin
    Thomas Gastinne
    Béatrice Mahé
    Viviane Dubruille
    Antoine Bonnet
    Anne Lok
    Patrice Chevallier
    Pierre Peterlin
    Alice Garnier
    Thierry Guillaume
    Amandine Le Bourgeois
    Steven Le Gouill
    Philippe Moreau
    Cyrille Touzeau
    [J]. Annals of Hematology, 2019, 98 : 1441 - 1447
  • [4] A SINGLE CENTER EXPERIENCE OF POMALIDOMIDE PLUS DEXAMETHASONE (PD) IN PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM)
    Duran, M.
    Tombuloglu, M.
    Tobu, M.
    Vural, F.
    Sahin, F.
    Patir, P.
    Uysal, A.
    Saydam, G.
    [J]. LEUKEMIA RESEARCH, 2016, 49 : S18 - S19
  • [5] A SINGLE-CENTER REAL-LIFE EXPERIENCE WITH BELANTAMAB MAFODOTIN IN RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Condorelli, A.
    Garibaldi, B.
    Gagliano, C.
    Romano, A.
    Ragusa, M.
    Del Fabro, V.
    Parrinello, N. L.
    Longo, A.
    Cosentino, S.
    Di Raimondo, F.
    Conticello, C.
    [J]. HAEMATOLOGICA, 2021, 106 (10) : 169 - 169
  • [6] Pomalidomide-based therapy in Relapsed/Refractory Multiple Myeloma: a real-world single-center experience.
    Fucci, Ludovica
    Fiori, Luciano
    Coppetelli, Ugo
    Cimino, Giuseppe
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S144 - S145
  • [7] REAL-LIFE EXPERIENCE WITH POMALIDOMIDE IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
    Cubillas, Garcia de la Torre Damian
    Inigo, Rodriguez Belen
    Alfayate, Lobo Ana
    Menendez, Cuevas Marina
    Bolanos, Calderon Estefania
    Medina, Salazar Sissy Fiorella
    Mateo, Morales Marta
    Pena, Cortijo Ascension
    Perez, Lopez Cristina
    Polo, Zarzuela Marta
    Calo, Perez Aida
    Colas, Lahuerta Blanca
    Gomez, Alvarez Miguel
    Escribano, Serrat Silvia
    Estival, Monteliu Pablo
    Gulino, Horacio
    Daorta, Melisa
    Moreno, Paredes Nahir Daniela
    Benavente, Cuesta Celina
    [J]. HAEMATOLOGICA, 2020, 105 : 151 - 151
  • [8] Daratumumab, lenalidomide, and dexamethasone combination in relapsed/refractory myeloma patients: a real-life single-center experience
    Antonioli, Elisabetta
    Staderini, Michela
    Pilerci, Sofia
    Perfetto, Federico
    Cappelli, Francesco
    Allinovi, Marco
    Nozzoli, Chiara
    Attucci, Irene
    Buzzichelli, Alessandra
    Messeri, Maria
    Bosi, Alberto
    [J]. LEUKEMIA & LYMPHOMA, 2020, 61 (13) : 3255 - 3258
  • [9] Pomalidomide and Dexamethasone Is an Effective Regimen for Advanced-Stage Relapsed/Refractory Multiple Myeloma: Experience of a Single Center
    Zepeda, Victor H. Jimenez
    Duggan, Peter
    Neri, Paola E.
    Bahlis, Nizar J.
    [J]. BLOOD, 2014, 124 (21)
  • [10] Long Term Disease Control with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients: A Real Life Experience
    Conticello, Concetta
    Parisi, Marina
    Leotta, Salvatore
    Parrinello, Nunziatina Laura
    Martino, Enrica
    Calafiore, Valeria
    Pirosa, Maria Cristina
    Markovic, Urosh
    Romano, Alessandra
    Di Raimondo, Francesco
    [J]. BLOOD, 2018, 132
12345